PATTERNS OF SUBRETINAL AND/OR INTRARETINAL FLUID RECURRENCE IN PATIENTS WHO RECEIVED AS-NEEDED RANIBIZUMAB THERAPY IN THE HARBOR TRIAL

To evaluate subretinal fluid (SRF) and/or intraretinal fluid recurrence in patients with neovascular age-related macular degeneration who received as-needed (PRN) ranibizumab in a HARBOR (NCT00891735) post hoc analysis. METHODS: Analyses included patients with SRF and/or intraretinal fluid at baseli...

Descripción completa

Detalles Bibliográficos
Autores principales: Adrean, Sean D., Chaili, Siyang, Hill, Lauren, Amador-Patarroyo, Manuel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2023
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035653/
https://www.ncbi.nlm.nih.gov/pubmed/36729084
http://dx.doi.org/10.1097/IAE.0000000000003708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035653/
https://www.ncbi.nlm.nih.gov/pubmed/36729084
http://dx.doi.org/10.1097/IAE.0000000000003708

Ejemplares similares